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An asymmetrical FIA merging-zones manifold based on the dual
injection of two sample microvolumes was developed for the
simultaneous determination ofsalicylic acid and acetylsalicylic acid
in pharmaceutical preparations at a sampling frequency of 30/h.
The complex formed between the Fe(III) reagent continuously
introduced in the system and salicylic acid was monitored
photometrically at 520 nm. One of the sample plugs was pre-
hydrolysed on injection into an NaOH stream and was circulated
through a longer channel than the otherplug. Thisyielded two FIA
peaks corresponding to salicylic acid and the overall content,
respectively. Theproposed manifoldwas successfully used to control
the dissolution test of a pharmaceutical preparation.
are circulated vary in length, so the latter reach the
detection point at a different time. The result is two FIA
peaks proportional to the free and overall analyte
concentration. An example of this approach is the
determination of free and combined sulphur dioxide in
wines by double stopped-flow injection analysis [12].
This paper reports the determination of salicylic (SA)
and acetylsalicylic (ASA) acid in pharmaceuticals by
using an FIA manifold. The wellknown colour-forming
complexation reaction between Fe(III) and salicylic acid
was monitored photometrically at 520 nm. Once opti-
mized, the manifold was applied to the dissolution testing
of aspirin tablets. Although SA had been previously
determined alone by FIA 13] and in mixtures with ASA
by HPLC [14], their simultaneous assay by the latter
technique, which is much more straightforward and
convenient, has not been addressed to date.
Introduction Experimental
Flow Injection Analysis (FIA) is by now a solidly
established analytical methodology [1-3], as reflected by
the large number of papers (over 2900) published on the
topic and by the variety of FIA analysers commercially
available. FIA is entering a new age in which it will
address real analytical problems. Thus, FIA can now be
regarded as a major alternative in the automation of
analytical processes; this is one of the main goals of
contemporary analytical chemistry according to the US
National Institute for Science and Technology (NIST)
[41.
The growing significance of the role played by analytical
chemistry in process control is now widely acknowledged
[5,6]. The ready implementation of on-line process
monitoring by using FIA analysers [7] allows for a fairly
high degree of automation, as compared with the at-line
and off-line alternatives, and facilitates calibration with
respect to in-line and invasive methodologies [8]. The
inherent advantages of FIA as an alternative to conven-
tional approaches to monitoring pharmaceutical dissolu-
tion tests [9] have been discussed in depth elsewhere 10].
A significant advantage is the possibility of determining
not only the active component in the sample, but also its
degradation products.
In addition, FIA allows the ready implementation of
speciation studies [11 ], such as the.determination of ti"ee
and combined analytes in various matrices by splitting
the injected sample plugs into two subplugs, one ofwhich
is usually subjected to a previous normally hydrolysis
reaction. The two channels through which the subplugs
Reagents
(1) Aqueous solution of Fe(NO3)3"9H20 of pH 2"4
containing 1"0 g/1 Fe(III).
(2) Aqueous 0"45M HC1 and 0"50MNaOH solutions.
(3) Aqueous "0 g/1 salicylic acid and 2"0 g/1 acetylsali-
cylic acid solutions from which more dilute solu-
tions were prepared as required.
All reagents used were of analytical grade.
Apparatus
A Pye-Unicam SP-500 single-beam spectrophotometer
furnished with a Hellma 178"12 QS flow-cell and
connected to a Radiometer recorder was used. A four-
channel Gilson Minipuls-2 peristaltic pump, provided
with a rate selector and a custom-made injection valve
consisting of two Rheodyne 5041 single injection valves,
was also used.
General procedure
The manifold used is shown in figure 1. The sample, an
aqueous solution containing SA, ASA or both, was
aspirated by means of the peristaltic pump and two
microvolumes were simultaneously inserted into two HC1
and NaOH streams, respectively, with the aid ofthe dual
injection valve. The NaOH channel was somewhat
longer and enacted the sample hydrolysis. By using an
asymmetrical merging-zones assembly, a stream of the
Fe(III) derivatizing reagent was merged with
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Indicator reaction
The monitored reaction was the formation of a blue
complex ()max 520 rim) between SA and Fe(III) in an
acid medium (pH 2"2-2"8). This required the use of an
Fe(III) solution of a sufficiently high concentration to
ensure adequate sensitivity, and a pH close to 2"4 to
preserve an appropriate acidity after mixing at the
NaOH-containing reactor in the hydrolysis stage. ASA
yields no coloured product with Fe(III).
Figure 1. FIA manifold for the simultaneous determination of
salicylic and acetylsalicylic acid. DIV: dual injection valve; D"
detector; W: waste. Forfurther details see text.
common channel after the confluence point, so the
sequential arrival of the two simultaneously injected
plugs at the detector gave rise to two FIA peaks due to the
absorbance of the comp!ex formed between SA and
Fe(III) in an acid medium. The first peak was due to SA
alone, while the second corresponded to the contribution
of the two acids.
Dissolution test
The manifold described above was modified for testing
the aqueous dissolution of commercial aspirin tablets via
the hydrolytic cleavage of acetylsalicylic acid (see figure
2). The closed FIA manifold used for this purpose
involved injecting the sample from a reservoir and
collecting the waste from the dual injection valve. Each
sample injection yielded two profiles corresponding to the
system releasing SA on hydrolysis, and to the overall,
constant concentration of ASA. In this way, dissolution
tests of commercial pharmaceutical preparations con-
taining ASA can be readily controlled by monitoring its
hydrolysis by FIA.
Results and discussion
Optimization of the system
Chemical variables
The chemical variables affecting the system performance
were the NaOH concentration used in the hydrolysis of
ASA; the Fe(III) concentration, which determined the
sensitivity level achieved, and the HC1 concentration
required to restore the medium acidity required for the
indicator reaction (formation of the FeSA complex).
FIA variables
The FIA variables optimized in this case were the sample
volumes injected via the loops of the dual valve, the flow-
rate and the reactor dimensions.
Table lists the ranges over which these variables were
assayed and the optimum values found.
Figures of merit
Determination ofSA
Under the optimum working conditions, SA standards of
concentrations between 100 and 1000 mg/1 were injected
into the proposed manifold. The calibration graph run
was linear over the range 100-600 mg/1 SA. The equation
of the calibration line obtained from the first peak was A
0" 163 + 1" x 10-
[AS], with a regression coefficient
larger than 0"99. The reproducibility (expressed as rsd)
found for 11 samples of SA, with a concentration of 400
mg/1 injected in triplicate, was _+0"36%, and the sample
throughput was 30 samples/h.
Chemistry of the process
Hydrolysis reaction
Aqueous SA solutions are stable in acid and alkaline
media; ASA solutions, on the other hand, undergo
hydrolysis according to:
[COOH COOH. CH3COOH
OOCCH3 + HO OH +
This process is accelerated in an alkaline medium. In this
work the hydrolytic cleavage of ASA was exploited by
having the second injection valve inserting the sample
into a longer reactor, L, through which a 0"5 M NaOH
solution was circulated to effect the hydrolysis; the AS
yielded in the reaction was driven to the shorter reactor,
L1 (containing 0"45 M HC1), and later with the Fe(III)
stream to obtain two sequential FIA peaks per injection of
the dual valve. The kinetics ofthe hydrolysis reaction was
reasonably fast and was completed by using 0"50 M
NaOH at the longer reactor, L (320 cm).
Determination ofASA
Under the optimum working conditions, ASA standards
of concentrations between 300 and 2000 mg/1 were
injected into the proposed manifold. The calibration
graph run was linear over the range 300-1800 mg/1ASA.
The equation of the calibration line obtained from the
second peak was A -0" 163 + 2" 13 x 10-
[AS], with a
regression coefficient larger than 0"99. The rsd, calcu-
lated as in the case for an ASA concentration of600 mg/1,
was +0"48%, and the sample throughput was 30
samples/h.
Determination of mixtures
To test the applicability of the proposed method to
SA-ASA mixtures, samples were diluted so that their
concentrations were within the above linear ranges. The
concentrations, recoveries and errors found (table 2)
testify to the highly encouraging performance of the
method.
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Figure 2. Implementation ofan automatic assemblyfor the monitoring ofthe dissolution ofan aspirin tablet (Bayer). (a) Evolving system
connected on-line to the FIA manifold in figure 1. (b) FIA signals obtained.
Table 1. Assayed ranges and optimum values of experimental variables.
Sample volume
[HC1] [NaOH] [Fe(IIi)] V1 V2 Flow rate
(mol/l) (mol/1) (g/ml) (1) (1) (ml/min)
Assayed range 0" 1-1.0 0’ 1-1 "0 100-200 30-300 30-300 0"5-5.0
Optimum value 0"45 0"50 1000 100 58 1"5
Reactor lengths: I1 20 cm; L2 320 cm.
Table 2. Determination ofSA-ASA mixtures.
[SA] [ASA]
Present Found Error Present Found Error
Sample (g/ml) (g/ml) (%) (g/ml) (g/ml) (%)
800 770 -3-7 1200 1202 +0"1
2 200 198 -1"0 600 666 +11.0
3 200 209 +4"5 1200 1235 +2"9
4 600 644 +7"3 1800 1638 -9"0
5 200 219 +9"5 1800 1763 -2’0
6 600 616 +2"6 600 629 +4"8
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Continuous monitoring of dissolution tests
One of the major current rends in the use of FIA is for
controlling natural, simulated and industrial processes. A
manifold has been adapted to monitor the hydrolytic
cleavage ofASA in commercial aspirin tablets. The first
peak obtained was due to the system evolution, while the
second resulted from the overall, constant concentration
ofASA in the system.
Conclusions
The results obtained in this work prove the suitability of
FIA for simultaneous determinations ofpharmacological
interest and in controlling simulated processes (dissolu-
tion tests), particularly when the active component ofthe
pharmaceutical cannot be sensed directly.
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